Mayfair Advisory Group LLC boosted its position in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY – Get Rating) by 28.3% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 10,190 shares of the medical instruments supplier's stock after purchasing an additional 2,245 shares during the period. Mayfair Advisory Group LLC's holdings in DENTSPLY SIRONA were worth $297,000 as of its most recent SEC filing.
Several other hedge funds also recently added to or reduced their stakes in the company. Macquarie Group Ltd. boosted its position in DENTSPLY SIRONA by 3.2% in the 2nd quarter. Macquarie Group Ltd. now owns 8,879 shares of the medical instruments supplier's stock valued at $318,000 after buying an additional 274 shares during the period. Park Avenue Securities LLC boosted its position in DENTSPLY SIRONA by 4.6% in the 2nd quarter. Park Avenue Securities LLC now owns 6,403 shares of the medical instruments supplier's stock valued at $229,000 after buying an additional 280 shares during the period. S&CO Inc. boosted its position in DENTSPLY SIRONA by 0.5% in the 2nd quarter. S&CO Inc. now owns 85,747 shares of the medical instruments supplier's stock valued at $3,063,000 after buying an additional 400 shares during the period. Mutual of America Capital Management LLC boosted its position in DENTSPLY SIRONA by 1.5% in the 3rd quarter. Mutual of America Capital Management LLC now owns 29,893 shares of the medical instruments supplier's stock valued at $847,000 after buying an additional 452 shares during the period. Finally, Diversified Trust Co boosted its position in DENTSPLY SIRONA by 2.5% in the 3rd quarter. Diversified Trust Co now owns 19,140 shares of the medical instruments supplier's stock valued at $543,000 after buying an additional 472 shares during the period. 98.52% of the stock is currently owned by institutional investors.
Get
DENTSPLY SIRONA alerts:
Wall Street Analyst Weigh In
Several research firms have issued reports on XRAY. StockNews.com began coverage on shares of DENTSPLY SIRONA in a research report on Wednesday, October 12th. They issued a "hold" rating for the company. UBS Group lowered their price target on shares of DENTSPLY SIRONA to $35.00 in a research report on Thursday, November 17th. William Blair raised shares of DENTSPLY SIRONA from an "underperform" rating to a "market perform" rating in a research report on Wednesday, January 11th. Evercore ISI upped their price target on shares of DENTSPLY SIRONA to $34.00 in a research report on Thursday, November 17th. Finally, The Goldman Sachs Group lowered their price target on shares of DENTSPLY SIRONA from $41.00 to $34.00 and set a "neutral" rating for the company in a research report on Wednesday, November 16th. Seven equities research analysts have rated the stock with a hold rating and three have given a buy rating to the company. According to MarketBeat.com, DENTSPLY SIRONA presently has an average rating of "Hold" and an average target price of $40.70.
DENTSPLY SIRONA Stock Performance
DENTSPLY SIRONA stock traded down $1.22 during mid-day trading on Friday, reaching $38.44. 1,525,744 shares of the company traded hands, compared to its average volume of 1,820,563. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.50 and a quick ratio of 1.04. DENTSPLY SIRONA Inc. has a fifty-two week low of $26.48 and a fifty-two week high of $58.70. The company has a market capitalization of $8.26 billion, a price-to-earnings ratio of 14.04, a price-to-earnings-growth ratio of 5.42 and a beta of 0.94. The firm's fifty day moving average is $33.43 and its two-hundred day moving average is $32.57.
DENTSPLY SIRONA (NASDAQ:XRAY – Get Rating) last issued its quarterly earnings results on Monday, November 14th. The medical instruments supplier reported $0.41 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.59 by ($0.18). DENTSPLY SIRONA had a negative net margin of 20.81% and a positive return on equity of 9.63%. The company had revenue of $947.00 million for the quarter, compared to analyst estimates of $1.01 billion. During the same quarter in the previous year, the company posted $0.68 EPS. The company's revenue for the quarter was down 8.9% compared to the same quarter last year. On average, equities research analysts expect that DENTSPLY SIRONA Inc. will post 1.96 earnings per share for the current fiscal year.
DENTSPLY SIRONA Announces Dividend
The business also recently declared a quarterly dividend, which was paid on Friday, January 13th. Shareholders of record on Friday, December 30th were paid a dividend of $0.125 per share. The ex-dividend date of this dividend was Thursday, December 29th. This represents a $0.50 dividend on an annualized basis and a yield of 1.30%.
About DENTSPLY SIRONA
(Get Rating)
Dentsply Sirona, Inc engages in the design, manufacture, sales and distribution of professional dental products and technologies. It operates through the following segments: Technologies and Equipment and Consumables. The Technologies and Equipment segments comprises dental technology, equipment and healthcare consumable products such as dental implants, laboratory dental products, computer-aided design and computer-aided manufacturing systems, imaging systems, treatment centers and consumable medical device products.
Featured Stories
- Get a free copy of the StockNews.com research report on DENTSPLY SIRONA (XRAY)
- MarketBeat Week in Review – 1/30 – 2/3
- Are Penny Stocks Worth it? Should You Invest in Penny Stocks?
- Zimmer Biomet Beats on Earnings, Growth May be Priced In
- AI Software Maker EPAM Boasts Biggest Tech-Sector Rally
- Ford Stock Going Forward After Big Earnings Flop
Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.
